Exclusive: Ziopharm Oncology CEO Wants To Disrupt The CAR-T Supply Chain – Benzinga
Benzinga |
Exclusive: Ziopharm Oncology CEO Wants To Disrupt The CAR–T Supply Chain
Benzinga Ziopharm Oncology Inc. (NASDAQ: ZIOP) has two goals. One is to disrupt the narrative around recurrent glioblastomas. The other is to disrupt the entire pharmaceutical supply chain. The latter pursuit isn't just a B2B revenue opportunity, it's meant to … |
